ORIC Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $110,780,000.
Profit Margin
| 2017 | 0 | -22.02M | |
|---|---|---|---|
| 2018 | 0 | -21.36M | |
| 2019 | 0 | -25.48M | |
| 2020 | 0 | -97.27M | |
| 2021 | 0 | -77.67M | |
| 2022 | 0 | -91.47M | |
| 2023 | 0 | -100.69M |
ORIC Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.03M | 966K | 897K | 970K | 1M | 0 | 900K |
Gross profit | -1.03M | -966K | -897K | -970K | -1M | 0 | -900K |
Operating exp. | |||||||
Research and development | 85.17M | 61.68M | 56.85M | 35.92M | 22.84M | 19.02M | 19.12M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | -900K |
Total operating expenses | 110.78M | 86.76M | 78.87M | 49.34M | 28.56M | 22.37M | 21.64M |
Operating income | -110.78M | -91.76M | -78.87M | -74.18M | -28.56M | -22.37M | -22.54M |
Other income (expenses), net | 10.08M | 2.64M | 156K | 483K | 1.68M | 233K | 512K |
Income before tax | -100.69M | -89.12M | -78.71M | -73.70M | -26.88M | -21.36M | -22.02M |
Income tax expense | 0 | 2.35M | -1.03M | 23.56M | -1.39M | -1.00M | 0 |
Net income | -100.69M | -91.47M | -77.67M | -97.27M | -25.48M | -21.36M | -22.02M |
Earnings per share | |||||||
Basic EPS | -1.96 | -2.31 | -2.05 | -4.43 | -0.85 | -1.12 | -0.74 |
Diluted EPS | -1.96 | -2.31 | -2.05 | -4.43 | -0.85 | -1.12 | -0.74 |
| Data source | Data source | Data source | Data source |